Active Ingredient(s):Becaplermin, rh-PDGF FDA Approved: * December 16, 1997 Pharm Company: *OMJ PHARMACEUTICALS Category:Ulcer
Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good wound care for the treatment of lower extremity diabetic neuropathic ulcers. It is also known as "platelet-derived growth factor BB".
1 Medical uses
3 Adverse effects
4 See also
6 External links
The drug is used for the treatment of diabet...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions